ALL
ALL
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
0
$0
Insider Sales
38
$229.70M
Total Volume
$229.70M
38 transactions
Net Activity
$229.70M
Net selling
Sentiment Rating
Heavy DistributionCEO Conviction Index
Liquidating / Profit Taking
Key Drivers
- •Heavy distribution: sales represent 100% of total transaction value.
- •CEO selling activity detected. Often driven by option expiration or diversification plans.
- •Significant liquidation: total sale value exceeds $10M.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Wilson Thomas J
COB, Pres, CEO
$166.91M total
Rizzo Mario
Chief Operating Officer-AIC
$18.94M total
Merten Jesse E
PresPersonalProperty-Liability
$14.57M total
Gupta Suren
President,Enterprise Solutions
$10.31M total
Dugenske John E
Pres, Invest. & Corp. Strategy
$8.89M total
Quick Actions
ALL has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. ALL ranks #34 in insider activity out of 569 tracked companies in its industry.
Over the last 90 days, corporate insiders at ALL (ALL) engaged in a total of 38 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 38 were sales. The total volume of insider trading reached $229.70M.
The net insider activity for ALL shows a net selling bias of $229.70M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Wilson Thomas J (COB, Pres, CEO), who traded 181.5K shares valued at $38.01M on May 30, 2025.
Ben Lamm’s Astromech Acquires Form Bio in $230M All-Stock Deal
Patrick, LCI Stockholders Overwhelmingly Approve All-Stock Merger
Better Dividend Stock for Retirees: Plains All American vs. Kraft Heinz
Costco Just Made a New All-Time High After Announcing a $30-Per-Share Special Dividend. Is the Stock a Buy Before Dec. 10?
Opinion: This closely watched investing guru just sold all of his stocks
Nasdaq erases all 2026 gains as AI sell-off dampens Anthropic’s second day of trading
Related News & Analyst Reports
Read original insights and educational research covering ALL and the Unknown sector.
The AI Circular Valuation Bubble: Inside the Venture-Cloud Loop
An in-depth investigation into how technology giants and AI startups engage in circular capital flows, investing venture capital in exchange for cloud services and hardware, creating a closed-loop economy that artificially inflates valuations.
The Spinoff Separation: Tracking Post-Spinoff Executive Ownership Trends
An investigation of corporate spinoffs, showing how executive equity allocations and post-separation insider transactions signal parent and subsidiary performance trajectories.
The Impact of Interest Rates on Insider Behavior: A Macro Analysis
When the Fed tightens, equity valuations fall, but insider purchase activity does not always follow the same pattern. This report examines three rate-hike cycles to show how rising rates affect the frequency and conviction of C-suite stock buys.
Sequoia Capital and the Mechanics of Venture Lock-Up Extensions
Sequoia Capital pioneered the use of voluntary lock-up extensions to signal portfolio company confidence. This report analyzes the market-price impact of Sequoia extension announcements and whether they have historically justified the delay.
The Role of Insider Trading in M&A: Deciphering the Pre-Merger Signals
M&A deals are the most fertile ground for illegal insider trading, and for legal cluster buys that signal a company is strategically attractive. This guide separates the legal signal from the illegal noise in M&A-adjacent Form 4 activity.
Venture-Backed Biotech IPOs: Inside the 2026 Buying Spree
2026 saw a resurgence of venture-backed biotech IPOs, accompanied by unusually high post-lockup insider buying. This report documents the specific Form 4 cluster events, purchase sizes, and 90-day price performance across a dozen recent biotech offerings.
FAQs About ALL Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for ALL.